Feb 28 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP ANNOUNCES Q4 AND FULL YEAR 2019
FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS
    * CELLULAR BIOMEDICINE - FULL EXTENT TO WHICH CORONAVIRUS
WILL
NEGATIVELY IMPACT BUSINESS & RESULTS IS HIGHLY UNCERTAIN &
CANNOT BE ACCURATELY PREDICTED
    * CELLULAR BIOMEDICINE GROUP SAYS CO HAS EXPERIENCED, &
EXPECT TO
CONTINUE TO EXPERIENCE, A SLOWDOWN IN PATIENT RECRUITMENT FOR
CLINICAL STUDIES
    * CELLULAR BIOMEDICINE GROUP SAYS CO IS MINDFUL OF ONGOING
RISKS
POSED BY CORONAVIRUS DISEASE, OR COVID-19

Source text for Eikon:  ID:nPn2S22kca 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))